Remifentanil versus dexmedetomidina como coadjuvantes de técnica anestésica padronizada em pacientes com obesidade mórbida
Remifentanil versus dexmedetomidine as coadjutants of standardized anesthetic technique in morbidly obese patients
Eliana Cristina Murari Sudré; Maria do Carmo Salvador; Giuseppina Elena Bruno; Dalton Valentim Vassallo; Gabriela Rocha Lauretti; Gilberto Neves Sudré Filho
Resumo
Palavras-chave
Abstract
Keywords
Referências
Schroder T, Nolte M, Kox WJ. Anesthesia in extreme obesity. Hertz. 2001;26:222-228.
Auler Jr JOC, Miyoshi E, Fernandes CR. The effects of abdominal opening on respiratory mechanics during general anesthesia in normal and morbidly obese patients: a comparative study. Anesth Analg. 2002;94:741-748.
Torres LM, Calderon E, Velazquez A. Remifentanil: Indications in anesthesia. Rev Esp Anestesiol Reanim. 1999;46:75-80.
Venn RM, Hell J, Grounds RM. Respiratory effects of dexmedetomidine in the surgical patient requiring intensive care. Crit Care. 2000;4:302-308.
Drummond G. Dexmedetomidine may be effective, but is it safe?. Br J Anaesth. 2002;88:454-455.
Capella RF, Capella JF, Mandec H. Vertical banded gastroplasty-gastric bypass: preliminary report. Obes Surg. 1991;1:389-395.
Adams JP, Murphy PG. Obesity in anaesthesia and intensive care. Br J Anaesth. 2000;85:91-108.
Casati A, Albertin A, Danelli G. Implementing sevoflurane anesthesia with small doses opioid for upper abdominal surgery: Postoperative respiratory function after either remifentanil or fentanyl. Minerva Anestesiol. 2001;67:621-628.
Torri G, Casati A, Comotti L et al. Wash-in and wash-out curves of sevoflurane and isoflurane in morbidly obese patients. Minerva Anestesiol. 2002;68:523-527.
Rigg JR, Jamrozik K, Myles PS. Epidural anaesthesia and analgesia and outcome of major surgery: a randomised trial. Lancet. 2002;359:1276-1282.
Drover DR, Lemmens HJ. Population pharmacodynamics and pharmacokinetics of remifentanil as a supplement to nitrous oxide anesthesia for elective abdominal surgery. Anesthesiology. 1998;89:869-877.
Egan TD, Huizinga B, Gupta SK. Remifentanil pharmacokinetics in obese versus lean patients. Anesthesiology. 1998;89:562-573.
Masuda T, Yamada H, Takada K. Bispectral index monitoring is useful to reduce total amount of propofol and to obtain immediate recovery after propofol anesthesia. Masui. 2002;51:394-399.
Zarate E, Latham P, White PF. Fast-track cardiac anesthesia: use of remifentanil combined with intrathecal morphine as an alternative to sufentanil during desflurane anesthesia. Anesth Analg. 2000;91:283-287.
Eichenberger A, Proietti S, Wicky S. Morbid obesity and postoperative pulmonary atelectasis: an underestimated problem. Anesth Analg. 2002;95:1788-1792.
Taylor RR, Kelly TM, Elliott CG. Hypoxemia after gastric bypass surgery for morbid obesity. Arch Surg. 1985;120:1298-1302.
Bailey PL, Sperry RJ, Johnson GK. Respiratory effects of clonidine alone and combined with morphine in humans. Anesthesiology. 1991;74:43-48.
Melero A, Vallés J, Vila P. Recuperación anestésica, intercambio gaseoso y función hepática y renal postoperatorios en pacientes con obesidad mórbida sometidos a cirugía bariátrica: comparación de los efectos del halotano, isoflurano y fentanil. Rev Esp Anestesiol Reanim. 1993;40:268-272.
Alexander R, Booth J, Olufolabi AJ. Comparison of remifentanil with alfentanil or suxamethonium following propofol anaesthesia for tracheal intubation. Anaesthesia. 1999;54:1032-1036.
Atkins M, White J, Ahmed K. Day surgery and body mass index: results of a national survey. Anaesthesia. 2002;57:180-182.
Blanco Engert R, Gascon M, Weiner R. Video-laparoscopic placement of adjustable gastric banding (lap-band) in the treatment of morbid obesity: Preliminary results after 407 interventions. Gastroenterol Hepatol. 2001;24:381-386.
Juvin P, Vadam C, Malek L. Postoperatory recovery after desflurane, propofol, or isoflurane anesthesia among morbidly obese patients: a prospective, randomized study. Anesth Analg. 2000;91:714-719.